Your browser doesn't support javascript.
loading
Advances in research on HBV inhibitors based on new targets (1): capsid protein inhibitors / 药学学报
Acta Pharmaceutica Sinica ; (12): 554-565, 2020.
Article in Zh | WPRIM | ID: wpr-820854
Responsible library: WPRO
ABSTRACT
Hepatitis B virus (HBV) capsid protein plays an important role in the life cycle, thus becoming an ideal target for drug design. Capsid protein inhibitors can exert a synergistic antiviral effect with nucleoside drugs by inhibiting the replication of HBV. This paper reviews the research progress of capsid protein inhibitors with different structural types from the perspective of medicinal chemistry.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Acta Pharmaceutica Sinica Year: 2020 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Acta Pharmaceutica Sinica Year: 2020 Type: Article